NRx Pharmaceuticals Inc. (NASDAQ:NRXP) went down by -2.40% from its latest closing price compared to the recent 1-year high of $4.08.
Is It Worth Investing in NRx Pharmaceuticals Inc. (NASDAQ :NRXP) Right Now?
Plus, the 36-month beta value for NRXP is at 1.00. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for NRx Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3.25, which is $2.03 above the current price. NRXP currently public float of 37.79M and currently shorts hold a 3.74% ratio of that float. Today, the average trading volume of NRXP was 368.55K shares.
NRXP’s Market Performance
NRXP stocks went down by 0.00% for the week, with a monthly jump of 14.68% and a quarterly performance of 60.32%, while its annual performance rate touched -71.33%. The volatility ratio for the week stands at 9.04% while the volatility levels for the past 30 days are set at 10.15% for NRx Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 3.65% for NRXP stocks with a simple moving average of 20.98% for the last 200 days.
NRXP Trading at 4.96% from the 50-Day Moving Average
After a stumble in the market that brought NRXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.10% of loss for the given period.
Volatility was left at 10.15%, however, over the last 30 days, the volatility rate increased by 9.04%, as shares surge +12.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +44.81% upper at present.
During the last 5 trading sessions, NRXP fell by -6.83%, which changed the moving average for the period of 200-days by -50.33% in comparison to the 20-day moving average, which settled at $1.1836. In addition, NRx Pharmaceuticals Inc. saw 12.61% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at NRXP starting from Willard Stephen H, who purchase 50,000 shares at the price of $1.17 back on Dec 16. After this action, Willard Stephen H now owns 50,000 shares of NRx Pharmaceuticals Inc., valued at $58,500 using the latest closing price.
VAN VOORHEES SETH, the CHIEF FINANCIAL OFFICER of NRx Pharmaceuticals Inc., purchase 30,000 shares at $1.10 during a trade that took place back on Dec 16, which means that VAN VOORHEES SETH is holding 46,337 shares at $33,000 based on the most recent closing price.
Stock Fundamentals for NRXP
Equity return is now at value -254.90, with -180.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.74.